PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
2.640
0.00 (0.00%)
Oct 14, 2026, 9:44 AM EDT - Market open
PAVmed Revenue
PAVmed had revenue of $33.00K in the quarter ending June 30, 2026, with 450.00% growth. This brings the company's revenue in the last twelve months to $112.00K, down -89.02% year-over-year. In the year 2025, PAVmed had annual revenue of $71.00K, down -97.63%. That makes PAVmed the 45,932nd largest company in the world by revenue and 6,756th in the United States.
Revenue (ttm)
$112.00K
Revenue Growth
-89.02%
P/S Ratio
164.83
Revenue / Employee
$2,732
Employees
41
Market Cap
18.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.00K | -2.92M | -97.63% |
| Dec 31, 2024 | 3.00M | 543.00K | 22.15% |
| Dec 31, 2023 | 2.45M | 2.08M | 550.40% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| IRIDEX | 51.57M |
| Baird Medical Investment Holdings | 24.49M |
| Lifeward | 21.82M |
| Pulsenmore | 14.13M |
| InspireMD | 10.84M |
| Axonex AI Group | 2.29M |
| Sintx Technologies | 1.33M |
PAVM News
- 22 days ago - Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways - PRNewsWire
- 6 weeks ago - PAVmed price target raised to $57 from $56 at Ascendiant - TheFly
- 1 month ago - PAVmed reports Q2 adjusted EPS (27c) vs. ($1.40) last year - TheFly
- 2 months ago - PAVmed Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - PAVmed Quarterly report: Q2 2026 - Filings
- 2 months ago - PAVmed Slides: Q2 2026 - Filings
- 2 months ago - PAVmed Earnings release: Q2 2026 - Filings
- 2 months ago - PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results - PRNewsWire